Leading Swedish HIV diagnostic supplier Cavidi has been awarded the Swecare Export Award for 2012. Cavidi gets the award with the following motivation from Swecare:
Cavidi is a company that has shown significant development in exports in the last years. They have a novel HIV “RT” diagnostic technology discovered in Uppsala that is now being successfully commercialized in Africa, India, and South East Asia.
Commenting on the award CEO John Reisky de Dubnic said. “We are proud to receive the Swecare Export Award as recognition of the progress we are making at Cavidi. The HIV diagnostics market is expected to be worth 4 billion USD by 2020 and we intend to be a leading player with our patented, robust, and reliable test methods.”
For more information about Swecare and the Swecare Export award please refer to http://www.swecare.com/activities/swecare-export-award